ALLO Allogene Therapeutics, Inc.
Healthcare$2.09+0.00%OpenMarket Cap: $509.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$6.43
Target (Median)
$6.43
Target Range
$3.85 - $9.00
Upside from current price: 207.7%
Rating Distribution
3 Strong Buy10 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-16 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-16 | JP Morgan | upgrade | Neutral | Underweight |
| 2026-04-15 | Jefferies | maintain | Buy | Buy |
| 2026-04-14 | Baird | maintain | Outperform | Outperform |
| 2026-04-14 | Argus Research | maintain | Market Perform | Market Perform |
| 2026-04-14 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-04-14 | Bernstein | maintain | Market Perform | Market Perform |
| 2026-03-13 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-13 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-01-09 | Citizens | upgrade | Market Outperform | Market Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.80 | $9.7M | 8 |
| Sun Dec 31 | $-0.71 | $96.4M | 11 |
| Mon Dec 31 | $-0.11 | $311.8M | 4 |
| Tue Dec 31 | $0.75 | $606.7M | 4 |